Literature DB >> 28192012

Impact of Gender on Satisfaction and Confidence in Cholesterol Control Among Veterans at Risk for Cardiovascular Disease.

Karen M Goldstein1,2, Karen M Stechuchak1, Leah L Zullig1,2, Eugene Z Oddone1,2, Maren K Olsen1,3, Felicia A McCant1, Lori A Bastian4,5, Bryan C Batch6, Hayden B Bosworth1,2,7,8.   

Abstract

BACKGROUND: Compared with men, women have poorer lipid control. Although potential causes of this disparity have been explored, it is unknown whether patient-centered factors such as satisfaction and confidence contribute. We evaluated (1) whether satisfaction with lipid control and confidence in ability to improve it vary by gender and (2) whether sociodemographic characteristics modify the association.
MATERIALS AND METHODS: We evaluated baseline survey responses from the Cardiovascular Intervention Improvement Telemedicine Study, including self-rated satisfaction with cholesterol levels and confidence in controlling cholesterol. Participants had poorly controlled hypertension and/or hypercholesterolemia.
RESULTS: A total of 428 veterans (15% women) participated. Compared with men, women had higher low-density lipoprotein values at 141.2 versus 121.7 mg/dL, respectively (p < 0.05), higher health literacy, and were less likely to have someone to help track their medications (all p < 0.05). In an adjusted model, women were less satisfied with their cholesterol levels than men with estimated mean scores of 4.3 versus 5.6 on a 1-10 Likert scale (p < 0.05). There was no significant difference in confidence by gender. Participants with support for tracking medications reported higher confidence levels than those without, estimated mean 7.8 versus 7.2 (p < 0.05).
CONCLUSIONS: Women veterans at high risk for cardiovascular disease were less satisfied with their lipid control than men; however, confidence in ability to improve lipid levels was similar. Veterans without someone to help to track medications were less confident, and women were less likely to have this type of social support. Lack of social support for medication tracking may be a factor in lingering gender-based disparities in hyperlipidemia.

Entities:  

Keywords:  chronic disease; disparities; health behavior; women's health

Mesh:

Substances:

Year:  2017        PMID: 28192012      PMCID: PMC5507731          DOI: 10.1089/jwh.2016.5739

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  70 in total

1.  Sex, Myocardial Infarction, and the Failure of Risk Scores in Women.

Authors:  Shilpa Agrawal; Jennifer Van Eyk; Kimia Sobhani; Janet Wei; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2015-08-19       Impact factor: 2.681

2.  Spousal support in a behavior change intervention for cholesterol management.

Authors:  Nina R Sperber; Margarete Sandelowski; Corrine I Voils
Journal:  Patient Educ Couns       Date:  2013-03-27

3.  Demographic determinants of response to statin medications.

Authors:  Catherine Cone; Glen Murata; Orrin Myers
Journal:  Am J Health Syst Pharm       Date:  2011-03-15       Impact factor: 2.637

4.  Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study.

Authors:  James P Sheppard; Kate Fletcher; Richard J McManus; Jonathan Mant
Journal:  Br J Gen Pract       Date:  2014-01       Impact factor: 5.386

5.  Motivators and de-motivators for adherence to a program of sustained walking.

Authors:  Nikki Coghill; Ashley R Cooper
Journal:  Prev Med       Date:  2009-05-05       Impact factor: 4.018

6.  Gender differences in achieving optimal lipid goals in patients with coronary artery disease.

Authors:  Brett M Victor; Valerie Teal; Lilian Ahedor; Dean G Karalis
Journal:  Am J Cardiol       Date:  2014-03-01       Impact factor: 2.778

7.  Comparison of Adherence to Guideline-Based Cholesterol Treatment Goals in Men Versus Women.

Authors:  Martin W Schoen; Rachel G Tabak; Joanne Salas; Jeffrey F Scherrer; Fred R Buckhold
Journal:  Am J Cardiol       Date:  2015-10-23       Impact factor: 2.778

8.  Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans.

Authors:  Varsha G Vimalananda; Donald R Miller; Timothy P Hofer; Robert G Holleman; Mandi L Klamerus; Eve A Kerr
Journal:  J Gen Intern Med       Date:  2013-07       Impact factor: 5.128

9.  Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension.

Authors:  Hubert Chen; Erika B Rosenzweig; S Karl Gotzkowsky; Carl Arneson; Andrew C Nelsen; Robert C Bourge
Journal:  Health Qual Life Outcomes       Date:  2013-03-06       Impact factor: 3.186

10.  The influence of social support on risk of acute cardiovascular diseases in female population aged 25-64 in Russia.

Authors:  Valery V Gafarov; Dmitry O Panov; Elena A Gromova; Igor V Gagulin; Almira V Gafarova
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

View more
  3 in total

1.  Barriers to cardiovascular disease preventive behaviors among OEF/OIF/OND women and men veterans.

Authors:  Casey E Cavanagh; Lindsey Rosman; Philip W Chui; Lori Bastian; Cynthia Brandt; Sally Haskell; Matthew M Burg
Journal:  Health Psychol       Date:  2020-01-30       Impact factor: 4.267

2.  Gender Differences in Outcomes Following a Pain-Free, Home-Based Exercise Program for Claudication.

Authors:  Roberto Manfredini; Nicola Lamberti; Fabio Manfredini; Sofia Straudi; Fabio Fabbian; Maria Aurora Rodriguez Borrego; Nino Basaglia; Juan Manuel Carmona Torres; Pablo Jesus Lopez Soto
Journal:  J Womens Health (Larchmt)       Date:  2018-09-15       Impact factor: 2.681

3.  Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study.

Authors:  Erin R Weeda; Kinfe G Bishu; Ralph Ward; R Neal Axon; David J Taber; Mulugeta Gebregziabher
Journal:  BMC Cardiovasc Disord       Date:  2020-10-15       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.